Recently, it was determined that the EGFR (Epidermal Growth Factor Receptor)-mutant and EGFR-tyrosine kinase inhibitors resistant NSCLC (non-small cell lung cancer) cells, but not normal human lung fibroblasts, are sensitive to lysine deprivation. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.